Literature DB >> 2463331

A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97.

K S Furukawa1, K Furukawa, F X Real, L J Old, K O Lloyd.   

Abstract

Analysis of antibodies present in the serum of melanoma patient FD has shown that they detect a unique tumor epitope present only on the autologous melanoma cell line SK-MEL-131. Previous results had shown that the unique FD epitope is carried on a common glycoprotein of approximately 90 kD, widely expressed on melanoma and a few other cell types. We now show by sequential radioimmunoprecipitation and partial amino acid sequencing that this common molecule is a previously recognized melanoma antigen, originally identified by mouse mAbs, designated gp95 or p97 (and also known as melanotransferrin). Thus, FD is the first of the class I (unique) melanoma antigens that has been characterized and related to a known cell surface molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463331      PMCID: PMC2189208          DOI: 10.1084/jem.169.2.585

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.

Authors:  M J Mattes; F X Real; K Furukawa; L J Old; K O Lloyd
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

2.  Human melanoma-associated antigen p97 is structurally and functionally related to transferrin.

Authors:  J P Brown; R M Hewick; I Hellström; K E Hellström; R F Doolittle; W J Dreyer
Journal:  Nature       Date:  1982-03-11       Impact factor: 49.962

3.  Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies.

Authors:  J P Brown; P W Wright; C E Hart; R G Woodbury; K E Hellström; I Hellström
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

4.  Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.

Authors:  J P Brown; R G Woodbury; C E Hart; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

5.  Detection of a human melanoma-associated antigen, p97, in histological sections of primary human melanomas.

Authors:  H J Garrigues; W Tilgen; I Hellstróm; W Franke; K E Hellström
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

Review 6.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

Authors:  L J Old
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

7.  Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.

Authors:  K O Lloyd; J Ng; W G Dippold
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

8.  Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.

Authors:  F X Real; A N Houghton; A P Albino; C Cordon-Cardo; M R Melamed; H F Oettgen; L J Old
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

9.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.

Authors:  F X Real; M J Mattes; A N Houghton; H F Oettgen; K O Lloyd; L J Old
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  6 in total

1.  Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity.

Authors:  Hiroshi Shiku; Toshitada Takahashi
Journal:  Cancer Immun       Date:  2012-05-01

Review 2.  Melanoma vaccines. Current status and future prospects.

Authors:  P Hersey
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 3.  Drug delivery issues in vaccine development.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

4.  Endo-beta-D-glucuronidase (heparanase) activity of heat-shock protein/tumour rejection antigen gp96.

Authors:  P K Srivastava
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

Review 5.  Specificity in cancer immunotherapy.

Authors:  Andrea Schietinger; Mary Philip; Hans Schreiber
Journal:  Semin Immunol       Date:  2008-08-05       Impact factor: 11.130

6.  The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.

Authors:  S Vijayasaradhi; B Bouchard; A N Houghton
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.